By Diagnostics World Staff
February 22, 2017 | Diagnostics World has announced the winner of its first Diagnostics World Early Innovator Awards program. The winner, Travis Schlappi from the California Institute of Technology, was announced at the 2017 Molecular Medicine Tri Conference in San Fransisco.
“We are pleased with the results of this year’s Early Innovator Awards program,” said Allison Proffitt, editorial director for Diagnostics World. “This is the award’s inaugural competition, and I couldn’t be more impressed with the competitive spirit of our applicants. It’s always a joy to reward work that asks great questions and seeks creative solutions.”
The Diagnostics World Early Innovator Awards program recognizes innovation and creativity in effectively recognizing and solving a real-world clinical, scientific, or organizational problem through the application of a unique solution.
For his award-winning entry, Travis Schlappi tackled the issue of phenotypically determining antibiotic susceptibility within the time frame of a doctor's visit. His solution, a method called “digital antibiotic susceptibility testing” (dAST), would assist doctors in determining antibiotic resistance profiles before prescribing an antibiotic.